Ferrons SPRL
The score of Ferrons shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +107 % Total assets -17 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Ferrons's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 15 Jun 2026
- Year ended 31 Dec 2024filed on 31 Jul 2025
- Year ended 31 Dec 2023filed on 19 Jul 2024
- Year ended 31 Dec 2022filed on 25 Jul 2023
- Year ended 31 Dec 2021filed on 12 Jul 2022
Ferrons's financial analysis
- Solvency33.3%sector median: 60.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Ferrons
Ferrons's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0899.196.532
- VAT number
- BE0899196532
- Peppol
- Registered · 0208:0899196532 · as of 09 Nov 2026
- Legal form
- SPRL
- Incorporated
- 10 Jul 2008
- Registered office
- 1742 Ternat
- Latest accounts
- 2025 · filed on 15 Jun 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
Ferrons (SPRL) has been based in Ternat since 2008, active in: research and experimental development on biotechnology. For 2025, it reports a net profit of 37 € and equity of 77,266 €; its revenue is not published. Its solvency stands at 33.3%, below the median of its sector (60.4%).
Companies similar to Ferrons
Companies in the same business, of comparable size and area, outside its group.
- SciLife Consulting Research and experimental development on natural sciences and engineering Kortenberg · balance sheet 198,474 €
- Mentana DX Research and experimental development on natural sciences and engineering Evergem · balance sheet 229,998 €
- Ergotrics Research and experimental development on natural sciences and engineering Turnhout · balance sheet 376,384 €
- Spectralys Biotech Research and experimental development on natural sciences and engineering Charleroi · balance sheet 444,695 €
- Grand Medical (Europe) Research and experimental development on natural sciences and engineering Niel · balance sheet 135,260 €
- Cell-Cell BIO Research and experimental development on natural sciences and engineering Ghent · balance sheet 990,571 €
- AnaLIStics Research and experimental development on natural sciences and engineering Kontich · balance sheet 208,698 €
- Flindr Labs Manufacture of pharmaceutical preparations Ghent · balance sheet 262,929 €
Frequently asked questions about Ferrons
What is the revenue of Ferrons?
Ferrons files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Ferrons?
In Belgium, the VAT number is the company number prefixed with BE: BE0899196532 for Ferrons, if the company is VAT-registered. Its company number (CBE) is 0899.196.532.
Where is the registered office of Ferrons?
According to the CBE register, the registered office of Ferrons is in 1742 Ternat.
What is the equity of Ferrons?
At the close of the 2025 financial year, the equity of Ferrons amounts to 77,266 €, a solvency of 33.3% of total assets.
Who manages Ferrons?
The register lists 1 active mandates at Ferrons. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Ferrons
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →